Search

Author/Creator Wassenberg, S

3. FRI0203 Golimumab in biologic-naÏve patients with established rheumatoid arthritis (RA), psoriatic arthritis (PSA) or ankylosing spondylitis (AS) - subanalysis from the non-interventional evaluation go-nice. (15th June 2017)

Authors:
Krüger, K; Burmester, GR; Wassenberg, S; Bohl-Bühler, M; Thomas, MH
Journal:
Annals of the rheumatic diseases
Issue:
Volume 76(2017)Supplement 2
Page Start:
558
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. FRI0217 Impact of rituximab in combination with leflunomide and rituximab retreatment with two different dosages on patient-reported outcomes: results from a multicenter randomized placebo controlled investigator initiated clinical trial in active rheumatoid arthritis (AMARA-STUDY). (15th June 2017)

Authors:
Köhm, M; Rossmanith, T; Dauth, S; Alten, R; Aringer, M; Backhaus, M; Burmester, G; Feist, E; Kellner, H; Krüger, K; Müller-Ladner, U; Rubbert-Roth, A; Tony, H-P; Wassenberg, S; Burkhardt, H; Behrens, F
Journal:
Annals of the rheumatic diseases
Issue:
Volume 76(2017)Supplement 2
Page Start:
565
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. OP0062 The fully human anti-tnf antibody adalimumab (d2e7) in combination with methotrexate (mtx) in the treatment of active rheumatoid arthritis: results of a 2-year study. (1st June 2001)

Authors:
Breedveld, FC; Allaart, CF; Rau, R; Herborn, G; Wassenberg, S; Kroot, EJ; Van Riel, PL; Van de Putte, LB; Böger, C; Schattenkirchner, M; Kempeni, J; Beck, K; Kupper, H
Journal:
Annals of the rheumatic diseases
Issue:
Volume 60(2001)Supplement 1
Page Start:
A479
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. SAT0159 Impact of participation in the adalimumab patient support program on functional and clinical outcomes among patients with rheumatoid arthritis: passion study. (15th June 2017)

Authors:
Bosch, F Van den; Ostor, A; Wassenberg, S; Anderson, JK; Chen, N; Wang, C; Garg, V; Kalabic, J
Journal:
Annals of the rheumatic diseases
Issue:
Volume 76(2017)Supplement 2
Page Start:
829
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. The Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT): results of radiographic analyses after 1 year. Issue 8 (26th January 2006)

Authors:
Kavanaugh, A; Antoni, C E; Gladman, D; Wassenberg, S; Zhou, B; Beutler, A; Keenan, G; Burmester, G; Furst, D E; Weisman, M H; Kalden, J R; Smolen, J; van der Heijde, D
Other Names:
group-author.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 65:Issue 8(2006)
Page Start:
1038
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. The influence of the SARS-CoV-2 lockdown on patients with inflammatory rheumatic diseases on their adherence to immunomodulatory medication: a cross sectional study over 3 months in Germany. (11th March 2021)

Authors:
Hasseli, R; Müller-Ladner, U; Keil, F; Broll, M; Dormann, A; Fräbel, C; Hermann, W; Heinmüller, C -J; Hoyer, B F; Löffler, F; Özden, F; Pfeiffer, U; Saech, J; Schneidereit, T; Schlesinger, A; Schwarting, A; Specker, C; Stapfer, G; Steinmüller, M; Storck-Müller, K
Journal:
Rheumatology
Issue:
Volume 60:Number SI(2021)
Page Start:
SI51
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. THU0394 Rheumatologists use different cut offs for disease activity in real life – the experience with golimumab in ankylosing spondylitis – a subanalysis from the non-interventional go-nice trial. (15th June 2017)

Authors:
Braun, J; Baraliakos, X; Kiltz, U; Krüger, K; Burmester, GR; Wassenberg, S; Thomas, MH
Journal:
Annals of the rheumatic diseases
Issue:
Volume 76(2017)Supplement 2
Page Start:
356
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗